Product
Dipeptidyl Peptidase 4 inhibitor
1 clinical trial
1 indication
Indication
Type 2 DiabetesClinical trial
The Effect of Semaglutide on Endothelial Function, Arterial Stiffness and Liver Indices in Patients Witn Type 2 Diabetes Mellitus and NAFLDStatus: Recruiting, Estimated PCD: 2023-03-01